Results 71 to 80 of about 493,830 (358)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Non-invasive electrical markers in patients with left ventricular hypertrophy.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2011
Introduction The left ventricular hypertrophy is related with the genesis of ventricular arrhythmiasand sudden death. Depending of the cause, different histologycalmodifications that generate different arrhythmogenic substrates, takesplace.
Nadia Sánchez Torres, Juan A. Álvarez Gómez, Margarita Dorantes Sánchez, Jesús Castro Hevia, Geovedy Martínez García, Irma Fernández Madero   +5 more
doaj  

Diagnostic electrocardiographic dyad criteria of emphysema in left ventricular hypertrophy

International Journal of COPD, 2013
Swapnil S Lanjewar,1 Lovely Chhabra,1 Vinod K Chaubey,1 Saurabh Joshi,1 Ganesh Kulkarni,1 Chandrasekhar Kothagundla,1 Sudesh Kaul,1 David H Spodick21Department of Internal Medicine, 2Department of Cardiovascular Medicine, Saint Vincent Hospital ...
Lanjewar SS, Chhabra L, Chaubey VK, Joshi S, Kulkarni G, Kothagundla C, Kaul S, Spodick DH   +7 more
doaj  

The Effect of “Unclassified” Blood Pressure Phenotypes on Left Ventricular Hypertrophy

Turkish Archives of Pediatrics
Objective: We aimed to evaluate the clinical significance of the “unclassified” blood pressure phenotypes on left ventricular hypertrophy in children.
Belde Kasap-Demir, Cemaliye Başaran, Tülay Demircan, Gökçen Erfidan, Özgür Özdemir-Şimşek, Seçil Arslansoyu-Çamlar, Demet Alaygut, Fatma Mutlubaş, Cem Karadeniz   +8 more
doaj   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Comparison of the association of brachial arterial pressure and parameters of central aortic pressure with left ventricular hypertrophy in the general population of Novosibirsk

Российский кардиологический журнал, 2019
Aim. There is evidence that central aortic blood pressure (BP) is more associated with left ventricular myocardial hypertrophy than brachial BP.
E. E. Tsvetkova, A. A. Kuznetsov, D. V. Denisova, Yu. I. Ragino, M. I. Voevoda   +4 more
doaj   +1 more source

The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.

PLoS ONE, 2019
BackgroundWe aimed to characterize gender specific left ventricular hypertrophy using a novel, accurate and less time demanding cardiac magnetic resonance (CMR) quantification method to differentiate physiological hypertrophy and hypertrophic ...
Csilla Czimbalmos, Ibolya Csecs, Attila Toth, Orsolya Kiss, Ferenc Imre Suhai, Nora Sydo, Zsofia Dohy, Astrid Apor, Bela Merkely, Hajnalka Vago   +9 more
doaj   +1 more source

Comparative study of the clinical and echodopplercardiographic aspects of left ventricular hypertrophy and hypertrophic cardiomyopathy in cats (Felis catus).

Brazilian Journal of Veterinary Medicine, 2019
The aim of the present study was to differentiate hypertrophic cardiomyopathy (HCM) from concentric left ventricular hypertrophy (CLVH) and to compare their echodopplercardiography measurements in random bred domestic cats.
Bruno Alberigi, Alexandre Bendas, Denisa Soares, Renan Demo, Mateus Almeida, Jonimar Paiva   +5 more
doaj   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source